When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BIIB - Sell-siders weigh in on Biogen Alzheimer drug after FDA acceptance of filing
Biogen Inc.
Sell-side analysts are generally bullish on an FDA nod on Biogen's (BIIB+8.8%) Alzheimer's disease (AD) med aducanumab. This morning, the company announced that the agency accepted its marketing application under Priority Review status with a March 7, 2021 action date.
More news on: Biogen Inc., Eisai Co., Ltd., Eisai Co., Ltd., Healthcare stocks news, Stocks on the move,